Announcements Trials
Browse Landscape

Phase

Phase 2 78Phase 3 24Phase 1 13Phase 1/2 10Phase 2/3 7Phase EARLY_PHASE1 3Phase NA 2Phase 4 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Medulloblastoma 1Leukemia, Biphenotypic, Acute 1

Interventions

Dexamethasone 13Saline Solution 8Bupivacaine 8Bevacizumab 8Tobacco Use Cessation Devices 7Specimen Handling 7Nivolumab 7Magnetic Resonance Spectroscopy 7Lenalidomide 7Fluorouracil 7pembrolizumab 6Rituximab 6Prednisone 6Letrozole 6Carboplatin 6Propofol 5Human Papillomavirus Recombinant Vaccine nonavalent 5trametinib 4lenvatinib 4dabrafenib 4cabozantinib 4anlotinib 4Trastuzumab 4Tamoxifen 4Standard of Care 4Sodium Chloride 4Ropivacaine 4Paclitaxel 4Immune Checkpoint Inhibitors 4Esomeprazole 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Methotrexate × 1 year × Clear all
NCT06289673 2026-05-01

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

St. Jude Children's Research Hospital

Phase 4 Recruiting
850 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02875314 2026-02-12

HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors

Nationwide Children's Hospital

Phase 4 Active not recruiting
250 enrolled
CNS

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡